COMPASS-Pathways-investor-presentation_Jan-25_JPM_updated-FLS.pdf

1、Transforming Mental Health CareInvestor PresentationJanuary 20252|Compass PathwaysDisclaimerCautionary Note Regarding ForwardCautionary Note Regarding Forward-Looking Statements Looking Statements This presentation includes“forward-looking statements”within the meaning of the Private Securities Liti

2、gation Reform Act of 1995,as amended.In some cases,you can identify forward-looking statements by terms such as“believe,”“continue,”“could,”“estimate,”“expect,”“may,”“might,”“plan,”“potential,”“project,”“should,”“target,”“will,”“would,”or the negative of these terms,and similar expressions intended

3、to identify forward-looking statements.However,not all forward-looking statements contain these identifying words.These forward-looking statements include express or implied statements relating to our financial guidance;our strategic plans or objectives;our expectations and projections about our fut

4、ure cash needs and financial results;the anticipated proceeds,if any,to be received from the exercise for cash of the warrants sold in the January 2025;our plans for a strategic reorganization,including a reduction in workforce,and our expectations regarding impact of and cost savings from our plann

5、ed reduction in workforce;our plans and expectations regarding our phase 3 trials in treatment-resistant depression(TRD),including our expectations regarding the time periods during which the results of the two Phase 3 trials will become available;the potential for the pivotal phase 3 program in TRD

6、,any future trials in PTSD,or other trials to support regulatory filings and approvals;our expectations regarding the safety or efficacy of our investigational COMP360 psilocybin treatment,including as a treatment for TRD,PTSD,and anorexia nervosa;our expectations regarding the benefits of our inves